| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/06/2002 | EP1177292A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/06/2002 | EP1177288A1 Tumour-associated antigen |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177285A1 Chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/06/2002 | EP1177214A1 49 human secreted proteins |
| 02/06/2002 | EP1177212A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses |
| 02/06/2002 | EP1177210A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus |
| 02/06/2002 | EP1177203A1 Collagen-binding proteins from enterococcal bacteria |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | EP1176980A1 Ccr4 antagonists in sepsis |
| 02/06/2002 | EP0835305A4 Cytokine that induces apoptosis |
| 02/06/2002 | EP0832105A4 Immunogenic peptides of prostate specific antigen |
| 02/06/2002 | EP0547163B1 Protein polyligands joined to a stable protein core |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334821A Humanized antibodies to gamma-interferon |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334343A Antibody for suppressing tumor growth, its derivative and its application |
| 02/05/2002 | US6344552 Compositions and methods comprising DNA sequences encoding B. burgdorferi polypeptides |
| 02/05/2002 | US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer |
| 02/05/2002 | US6344544 Semaphorin-specific antibodies |
| 02/05/2002 | US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome |
| 02/05/2002 | US6344540 An isolated transcriptional activator polypeptide; screening antibiotics; therapy for staphyloccal infections |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344440 Antisecretory factor peptides regulating pathological permeability changes |
| 02/05/2002 | US6344356 Methods for recombining nucleic acids |
| 02/05/2002 | US6344339 Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR) |
| 02/05/2002 | US6344337 Antigen test to detect equine protozoal myeloencephalitis in horse serum and cerebrospinal fluid |
| 02/05/2002 | US6344314 Determined DNA sequenced derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
| 02/05/2002 | US6344202 Nucleotide sequence encodes major outer membrane proteins, generates antibodies that react with promoter sequence for expression in the host; drugs, vaccines |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2098113C Substances of polypeptide nature useful in human therapy |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/03/2002 | CA2340783A1 Ampk-related serine/threonine kinase, designated snark |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008765A2 Basal cell markers in breast cancer and uses thereof |
| 01/31/2002 | WO2002008757A1 Method for immuno-detection of epitopes |
| 01/31/2002 | WO2002008442A2 Means and methods for raising antibody concentration in compartments of the body of a non human animal |
| 01/31/2002 | WO2002008416A1 Method of preparing antibody by gene immunization |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008381A2 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
| 01/31/2002 | WO2002008294A1 Diagnosis and treatment of hhv-8 associated diseases based on the hhv-8 coded chemokine receptor |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008291A2 Multi-specific reagent for selective stimulation of cell surface receptors |
| 01/31/2002 | WO2002008288A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008282A2 Bstp-ras/rerg protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008281A2 Bstp-cad protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008262A2 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008261A2 Bstp-trans protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008260A2 Bstp-ecg1 protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008253A2 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 01/31/2002 | WO2002008252A2 Novel protein containing ring finger domaine r1p4 |
| 01/31/2002 | WO2002007762A1 Human tumor necrosis factor receptors tr21 and tr22 |
| 01/31/2002 | WO2002007760A2 Therapeutic agent against aids comprising anti hiv goat antibody |
| 01/31/2002 | WO2002007755A1 Lrp-mediated modulation of neuronal calcium influx via nmda receptors, and uses thereof |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001077321A3 Identification of a human gaba transporter |
| 01/31/2002 | WO2001068146A3 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 01/31/2002 | WO2001062940A3 New phosphodiesterase type 7b |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001048485A3 Selecting library members capable of binding to epitopes |
| 01/31/2002 | WO2001040473A3 Pseudomonas aeruginosa antigens |
| 01/31/2002 | WO2001038503A3 Novel human protein kinases and protein kinase-like enzymes |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001034177A3 Method of treating a viral infection using antagonists of macrophage colony stimulating factor |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001029085A3 Cdt6 can inhibit angiogenesis and tumor growth, and can induce or enhance the formation of structures containing collagen v |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000059941A9 Purposeful movement of human migratory cells away from an agent source |
| 01/31/2002 | US20020013485 Cytotoxic agents comprising taxanes and their therapeutic use |
| 01/31/2002 | US20020013456 Cortistatin: neuropeptides, compositions and methods |
| 01/31/2002 | US20020013455 Isolation and identification of novel polymerases |
| 01/31/2002 | US20020013453 Immunoglobulins; for use in diagnosis and treatment of huntington's disease |
| 01/31/2002 | US20020013452 Nucleotide sequences coding cytokine; for use in cancer treatment |
| 01/31/2002 | US20020013286 Administering the adenoviral gene transfer vector (exogenous) encoding a gene product to a muscle and the vector is neutralized outside of the muscle by systemic neutralizing antibodies; using a chimeric coat protein for cell entry |
| 01/31/2002 | US20020013285 Nucleosome-based anti-tumor compositions |
| 01/31/2002 | US20020013274 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 01/31/2002 | US20020013263 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/31/2002 | US20020013259 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 01/31/2002 | US20020012991 Nutrient broth; for use in the generation of monoclonal antibodies and preferential particles; for use in maintenance of cell viability |
| 01/31/2002 | US20020012989 Genetically engineered nucleotide sequences coding preferential proteins for use in treatment of viral disease |
| 01/31/2002 | US20020012966 18 Human secreted proteins |
| 01/31/2002 | US20020012965 Nucleotide sequences coding prfeerential polypeptides for use in the diagnosis and treatment of brain disorders and injury |
| 01/31/2002 | US20020012954 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 01/31/2002 | US20020012950 Screening for tumor metastasis; monitor sample for tumor marker protein expression, compare to control, evaluate tumor metastasis |
| 01/31/2002 | US20020012942 Polypeptides; for use in the diagnosis and treatment of cancer; antitumor agents; anticarcinogenic agents |